{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1","upperLimit":"8","value":"2.00"}]}],"title":"Cycle 1 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1","upperLimit":"8","value":"2.08"}]}],"title":"Cycle 1 day 15"}],"denoms":[{"counts":[{"groupId":"OG000","value":"28"}],"units":"Participants"}],"description":"Time to maximum observed serum concentration of Pomalidomide was reported.","dispersionType":"Full Range","groups":[{"description":"All participants treated with pomalidomide 5 mg by mouth (p.o.) for 21 of 28 days.","id":"OG000","title":"All Participants - Pomalidomide 5mg Daily"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"At pre-dose, 1, 2, 3, 4, 6, and 8 hours after dose on Cycle 1 Day 1, and pre-dose, 1, 2, 3, 4, 6, 8, and 24 hours after dose on Cycle 1 Day 15.","title":"Time to Maximum Observed Serum Concentration of Pomalidomide (Cmax)","type":"PRIMARY","unitOfMeasure":"hours"}